Delivering DermIdentical Twins

Spear Pharmaceuticals, under the supervision of a dermatologist, conceives and specifies the development of DermIdentical™ dermatology products to ensure the therapeutic and budgetary needs of your patients.

DermIdentical™ products are designed to deliver the same texture and consistency as the brand. In addition, they are proven bioequivalent to branded products in large, double-blind clinical trials.

News/Press Releases

Spear Pharmaceutical Inc.’s ANDA for Fluorouracil Cream 5%
Tretinoin Cream .05% (Emollient) approved by FDA as first generic to Renova®

From the President

“Instead of helping patients one at a time in my office, I now help people thousands at a time by giving them access to newly-developed branded and bioequivalent products that are safe, effective and FDA-approved.”

-K.L. Spear, M.D.
President and Dermatologist

About Spear Pharmaceuticals

Spear Pharmaceuticals is a specialty Dermatology company that develops important branded and bioequivalent products that help improve people's appearances and change their lives.